Caroline Lefeuvre

Dr. Caroline Lefeuvre

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Journal of Infection
Verified
Journal Article
Closed access
CLCaroline Lefeuvre
Caroline Lefeuvre
APAdeline Pivert
Adeline Pivert
HGHélène Le Guillou-Guillemette
Hélène Le Guillou-Guillemette
FLFrançoise Lunel-Fabiani
Françoise Lunel-Fabiani
PVPascal Veillon
Pascal Veillon
ADAlexandra Ducancelle
Alexandra Ducancelle

Verified
Journal Article
Open access
PDF file
CLCaroline Lefeuvre
Caroline Lefeuvre
HGHélène Le Guillou-Guillemette
Hélène Le Guillou-Guillemette
ADAlexandra Ducancelle
Alexandra Ducancelle
Chronic hepatitis B virus (HBV) infection is one of the most common factors associated with hepatocellular carcinoma (HCC), which is the sixth most prevalent cancer among all cancers worldwide. However, the pathogenesis of HBV-mediated hepatocarcinogenesis is unclear. Evidence currently available suggests that the HBV core protein (HBc) plays a potential role in the development of HCC, such as the HBV X protein. The core protein, which is the structural component of the viral nucleocapsid, contributes to almost every stage of the HBV life cycle and occupies diverse roles in HBV replication and pathogenesis. Recent studies have shown that HBc was able to disrupt various pathways involved in liver carcinogenesis: the signaling pathways implicated in migration and proliferation of hepatoma cells, apoptosis pathways, and cell metabolic pathways inducing the development of HCC; and the immune system, through the expression and production of proinflammatory cytokines. In addition, HBc can modulate normal functions of hepatocytes through disrupting human host gene expression by binding to promoter regions. This HBV protein also promotes HCC metastasis through epigenetic alterations, such as micro-RNA. This review focuses on the molecular pathogenesis of the HBc protein in HBV-induced HCC.

24 February 2022 in International Journal of Public Health
Verified
Journal Article
Open access
CLCaroline Lefeuvre
Caroline Lefeuvre
HPHélène De Pauw
Hélène De Pauw
ABAnne-Sophie Le Duc Banaszuk
Anne-Sophie Le Duc Banaszuk
APAdeline Pivert
Adeline Pivert
ADAlexandra Ducancelle
Alexandra Ducancelle
MAMarc Arbyn
Marc Arbyn
Objectives: The cervical cancer screening coverage remains moderate (60%) in France. The aim of the study is to evaluate the efficacy of two experimental invitation strategies (offer of urine or vaginal self-sampling kits) to reach under-screened populations and compare them with the current invitation strategy in rural departments (low medical density and low participation rate) in France.Methods: The study is a randomised controlled trial with three arms: a control arm (conventional invitation letter) and two experimental arms (mailing of a urine or vaginal self-sampling kit). The target population includes women aged 30–65 years, who had no screening test recorded since more than 4 years and who did not respond to an invitation letter within 12 months before. The primary outcome measure is the participation rate in each arm. A team of psychologists will also investigate attitudes and experiences by semi-structured/focus-group interviews with voluntary CapU4 participants and with health professionals.Result and conclusion: CapU4 will identify effective strategies to reach women not responding to current screening invitations and will generate information about acceptance of self-sampling among women and health professionals.

1 January 2022 in Emerging Infectious Diseases
Verified
Journal Article
Open access
CLCaroline Lefeuvre
Caroline Lefeuvre
CLCaroline Lefort
Caroline Lefort
FBFrançoise Boyer
Françoise Boyer
SCSophie Le Cam
Sophie Le Cam
LMLina Mouna
Lina Mouna
RMRafaël Mahieu
Rafaël Mahieu
Transfusion-Transmitted Hepatitis A Virus, France

26 October 2023 in Cancers
Verified
Journal Article
Open access
PDF file
JGJohane Le Goff
Johane Le Goff
ADAnne-Sophie Le Duc-Banaszuk
Anne-Sophie Le Duc-Banaszuk
CLCaroline Lefeuvre
Caroline Lefeuvre
APAdeline Pivert
Adeline Pivert
ADAlexandra Ducancelle
Alexandra Ducancelle
FRFranck Rexand-Galais
Franck Rexand-Galais
Self-sampling may improve participation in cervical cancer secondary prevention programs by women who do not respond or respond irregularly when invited to contact a health professional for the collection of a cervical specimen. It could also help resolve access problems in areas with a low physician density. The present qualitative study examined barriers to screening, effective screening strategies, and the advantages and disadvantages of sending women urine or vaginal self-sampling kits in two medically underserved administrative departments in France (Mayenne and Sarthe) showing low cervical screening coverage. As part of the CapU4 randomized trial, a team of psychologists investigated the attitudes and experiences of 59 healthcare professionals (gynecologists, general practitioners, and midwives) through semi-structured interviews. Results indicated that health professionals believe that self-sampling may address the issues of low physician density and underscreening by removing logistical, organizational, financial, and psychological obstacles. They confirmed trust in the use of vaginal self-sampling, with urine self-sampling as an alternative solution (e.g., for women with vaginismus). The health professionals also identified several limitations of the self-sampling kit that will need to be addressed in future screening campaigns (incomplete kit, complex instructions, poor anatomical knowledge, and obesity).

29 July 2021 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
CLCaroline Lefeuvre
Caroline Lefeuvre
MSMaud Salmona
Maud Salmona
LBLouise Bondeelle
Louise Bondeelle
VHVéronique Houdouin
Véronique Houdouin
LFLinda Feghoul
Linda Feghoul
JLJérôme LeGoff
Jérôme LeGoff